0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
Editorial |

Notice of Retraction: Sato Y, et al. The Prevention of Hip Fracture With Risedronate and Ergocalciferol Plus Calcium Supplementation in Elderly Women With Alzheimer Disease: A Randomized Controlled Trial. Arch Intern Med. 2005;165(15):1737-1742.

Howard Bauchner, MD1; Rita F. Redberg, MD, MSc2,3
[+] Author Affiliations
1Editor in Chief, JAMA
2Editor, JAMA Internal Medicine
3Department of Medicine, University of California, San Francisco
JAMA Intern Med. 2016;176(9):1256. doi:10.1001/jamainternmed.2016.3177.
Text Size: A A A
Published online

Extract

An article by Sato et al has been retracted.

The following article, Sato Y, Kanoko T, Satoh K, Iwamoto J. The prevention of hip fracture with risedronate and ergocalciferol plus calcium supplementation in elderly women with Alzheimer disease: a randomized controlled trial. Arch Intern Med. 2005;165(15):1737-1742,1 has been retracted due to acknowledgment of scientific misconduct resulting in concerns about data integrity and inappropriate assignment of authorship.

Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

First Page Preview

View Large
First page PDF preview

Figures

Tables

References

Correspondence

CME
Also Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
Please click the checkbox indicating that you have read the full article in order to submit your answers.
Your answers have been saved for later.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.
Submit a Comment
“Notice of Retraction”- The patients and society.
Posted on July 2, 2016
Dr.Rajiv Kumar, Dr.Jagjit Singh.
Faculty, Deptt. of Pharmacology. Government Medical College & Hospital, Chandigarh, 160030, India.
Conflict of Interest: None Declared
We are sincerely thankful to the Editor in Chief, JAMA and the Editor, JAMA Internal Medicine for giving “Notice of Retraction” to Sato Y, et al., due to acknowledgment of scientific misconduct.
This research paper (now retracted research paper) has an Altmetric score of 6, which is a high-level measure of the quality and quantity of online attention, 1blog post & 33 citations so far.
But this raises many questions in the scientific community because the articles published in journals of JAMA network are accepted by the academics and researchers wholeheartedly all over the world.
This research paper published in Aug, 2005 and “Notice of Retraction” issued this year (Published Online: June 3, 2016. doi:10.1001/jamainternmed. 2016.3177), within this period the scientific community well utilized the facts of this article for research purpose, for meta-analysis, for research projects, and to prepare guidelines by the scientific bodies all over the world.
The time-money and manpower has been affected, but the pharmaceutical companies got benefits most.
The patients and society is affected largely more than others and it looks that cheated, ultimately affect faith and trust to the journal and its published articles.

Regards ,
Dr Rajiv Kumar, Dr Jagjit Singh. Faculty, Deptt. of Pharmacology. Government Medical College & Hospital, Chandigarh, 160030, India.
DRrajiv.08@gmail.com


Submit a Comment

Multimedia

Some tools below are only available to our subscribers or users with an online account.

2,705 Views
0 Citations
×

Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

Related Content

Customize your page view by dragging & repositioning the boxes below.

Articles Related By Topic
Related Collections
PubMed Articles
Jobs
JAMAevidence.com

Care at the Close of Life: Evidence and Experience
Alzheimer Disease: "It's OK, Mama, If You Want to Go, It's OK"

The Rational Clinical Examination: Evidence-Based Clinical Diagnosis
Supplemental Content

brightcove.createExperiences();